U.S. Physical Therapy (NYSE:USPH) Earns Outperform Rating from Analysts at JMP Securities

Research analysts at JMP Securities began coverage on shares of U.S. Physical Therapy (NYSE:USPH) in a note issued to investors on Monday,Briefing.com Automated Import reports. The firm set an “outperform” rating and a $113.00 price target on the stock. JMP Securities’ price objective would indicate a potential upside of 20.91% from the company’s previous close.

Several other analysts have also commented on the company. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the company from $100.00 to $115.00 in a research note on Monday. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. JPMorgan Chase & Co. upped their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus price target of $114.00.

U.S. Physical Therapy Stock Performance

USPH opened at $93.46 on Monday. The stock has a market cap of $1.41 billion, a PE ratio of 99.43, a P/E/G ratio of 4.23 and a beta of 1.46. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63. The stock’s 50 day simple moving average is $89.32 and its 200-day simple moving average is $89.89. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

Insider Activity

In other news, Director Bernard A. Harris, Jr. sold 2,000 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the transaction, the director now directly owns 16,726 shares in the company, valued at $1,554,681.70. The trade was a 10.68 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,412 shares of company stock worth $706,605 over the last three months. Corporate insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. grew its position in shares of U.S. Physical Therapy by 18.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after purchasing an additional 186 shares in the last quarter. Fifth Third Bancorp raised its holdings in U.S. Physical Therapy by 41.4% in the 2nd quarter. Fifth Third Bancorp now owns 1,332 shares of the company’s stock valued at $123,000 after acquiring an additional 390 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of U.S. Physical Therapy by 37.7% during the 2nd quarter. SG Americas Securities LLC now owns 5,924 shares of the company’s stock valued at $547,000 after acquiring an additional 1,623 shares during the period. BNP Paribas Financial Markets grew its holdings in shares of U.S. Physical Therapy by 283.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after purchasing an additional 956 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.